Genomic biomarkers in prostate cancer

Prostate cancer is the most common non-cutaneous cancer among men in the United States. In the last decade there has been a rapid expansion in the field of biomarker assays for diagnosis, prognosis, and treatment prediction in prostate cancer. The evidence base for these assays is rapidly evolving....

Descripción completa

Detalles Bibliográficos
Autores principales: Kornberg, Zachary, Cooperberg, Matthew R., Spratt, Daniel E., Feng, Felix Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043739/
https://www.ncbi.nlm.nih.gov/pubmed/30050804
http://dx.doi.org/10.21037/tau.2018.06.02

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043739/
https://www.ncbi.nlm.nih.gov/pubmed/30050804
http://dx.doi.org/10.21037/tau.2018.06.02

Ejemplares similares